The weekly litigation news digest is live. Subscribe now

IP Verse

N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)-Phenyl]-Acetamide Free Base Hemihydrate, Methods Of Manufacture And Uses Thereof - EP3544976

The patent EP3544976 was granted to Aicuris on Feb 17, 2021. The application was filed on Nov 28, 2017 under application number EP17811883A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3544976

AICURIS
Application Number
EP17811883A
Filing Date
Nov 28, 2017
Status
Opposition Rejected
Feb 23, 2024
Publication Date
Feb 17, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
INNOVATIVE MOLECULESNov 17, 2021GILLE HRABAL PARTNERSCHAFTSGESELLSCHAFT MBB PATENTANWALTE -

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2006103011
INTERNATIONAL-SEARCH-REPORTWO0147904
INTERNATIONAL-SEARCH-REPORTWO2006103011
INTERNATIONAL-SEARCH-REPORTWO2013045491
OPPOSITIONWO0147904
OPPOSITIONWO03000259
OPPOSITIONWO2006103011
OPPOSITIONWO2013045491

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents